Dipal Doshi owns 1.33% of Entrada Therapeutics
517,290 shares as of the September 2, 2026 filing, worth $2.3M at the latest close.
TRDA · $170M market capGet an email when Dipal Doshi’s stake moves.
Free.
The stake
1.33%
worth $2.3M at the latest close
Stake rank
#2,421
by dollar value of the stake
Last sale
826 days ago
Jul 15, 2024
Last buy
None
no purchases since 2022
Dipal Doshi owns 1.33% of Entrada Therapeutics, Inc.: 517,290 of 38,936,669 shares, worth about $2.3M at the 2026-10-16 close. The stake has moved from 0.56% in 2021 to 1.33% on 2026-09-02, across 27 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $33,897 on 2024-07-15.
How the stake is held
as of the Sep 2, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Sep 2, 2026 · Form 4 ↗
HELD DIRECTLY
517,290
100.0%
THE STAKE
517,290
1.33%